PIRAMAL PHARMA
|
The Current P/S Ratio of PIRAMAL PHARMA is 2.40.
| Share Price | ₹160.4 | Feb 20,2026 |
| Market Cap | ₹21,320.4 Cr | |
| Sales-TTM | ₹8,871.4 Cr | TTM-Consolidated Results |
| Price/Sales | 2.40x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹21,320.4 Cr] as on Feb 20,2026
(/) Sales [ ₹8,871.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.40x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '2.40 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !
The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA
PS Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.30x.
- PIRAMAL PHARMA 's operated at median p/e ratio of 1.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2025 at 3.25x.
- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| PIRAMAL PHARMA | 8,871.4 | 2.40 | 21,320.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.28 | 413,753.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.19 | 167,032.0 |
| CIPLA LTD | 28,351.1 | 3.82 | 108,360.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.26 | 143,426.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.08 | 106,859.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.01 | 83,688.0 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.48 | 90,661.7 |
| LUPIN LTD | 26,150.5 | 3.88 | 101,450.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.03 | 67,358.5 |
| ABBOTT INDIA LTD | 6,824.1 | 8.18 | 55,807.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.03x |
| Max industry PS | 16.19x |
| Median industry PS | 3.88x |
| Average industry PS | 6.15x |
You may also like the below Video Courses